Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies

被引:59
作者
Chen, Zhen-Feng [1 ]
Liu, Yan-Cheng [1 ,3 ]
Liu, Li-Min [2 ]
Wang, Heng-Shan [1 ]
Qin, San-Hai [2 ]
Wang, Bo-Long [2 ]
Bian, He-Dong [1 ]
Yang, Bin [2 ]
Fun, Hoong-Kun [4 ]
Liu, Hua-Gang [2 ]
Liang, Hong [1 ,3 ]
Orvig, Chris [5 ]
机构
[1] Guangxi Normal Univ, Sch Chem & Chem Engn, Minist Educ, Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China
[2] Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China
[3] Nankai Univ, Sch Chem, Tianjin 300071, Peoples R China
[4] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, George Town 11800, Malaysia
[5] Univ British Columbia, Dept Chem, Med Inorgan Chem Grp, Vancouver, BC V6T 1Z1, Canada
基金
中国国家自然科学基金;
关键词
RUTHENIUM(II) COMPLEXES; PLATINUM(II) COMPLEXES; CYTOTOXIC ACTIVITY; TOPOISOMERASE-II; FLUORESCENCE; CISPLATIN; DERIVATIVES; INHIBITION; ALKALOIDS; ETHIDIUM;
D O I
10.1039/b813363h
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Liriodenine (L), an active component of the anticancer traditional Chinese medicine (TCM), was isolated from Zanthoxylum nitidum. Its reactions with Pt(II) and Ru(II) afforded three metal complexes: cis-[PtCl2(L)] (1), cis-[PtCl2(L)(DMSO)] (2), and cis-[RuCl2(L)(DMSO)(2)]center dot 1.5H(2)O (3), the crystal structures of L, 2 and 3 were determined by single-crystal X-ray diffraction methods. These complexes were fully characterized by elemental analysis, IR spectrophotometry, H-1 and C-13 NMR spectroscopies, and ES mass spectrometry. The in vitro cytotoxicity of L and complexes 1-3 against 11 human tumour cell lines was assayed. The metal-based compounds exhibit enhanced cytotoxicity vs. free L, suggesting that these compounds display synergy in the combination of metal ions and liriodenine. The binding properties of L and its complexes 1-3 to ct-DNA were investigated through UV-vis, fluorescence, CD spectra, viscosity and agarose gels electrophoretic measurements.
引用
收藏
页码:262 / 272
页数:11
相关论文
共 68 条
[1]   Chemical properties and cytotoxic activity of complexes of platinum(II) and palladium(II) containing dmso and various anions;: synthesis and structural characterization of [Pt(dmso)2{O2(CO)2CCH2CH2CH2}] [J].
Al-Allaf, TAK ;
Rashan, LJ ;
Abu-Surrah, AS ;
Fawzi, R ;
Steimann, M .
TRANSITION METAL CHEMISTRY, 1998, 23 (04) :403-406
[2]   SYNTHESIS, CHARACTERIZATION, AND DNA-BINDING PROPERTIES OF (1,2-DIAMINOETHANE)PLATINUM(II) COMPLEXES LINKED TO THE DNA INTERCALATOR ACRIDINE-ORANGE BY TRIMETHYLENE AND HEXAMETHYLENE CHAINS [J].
BOWLER, BE ;
AHMED, KJ ;
SUNDQUIST, WI ;
HOLLIS, LS ;
WHANG, EE ;
LIPPARD, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (04) :1299-1306
[3]   DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity [J].
Brabec, Viktor ;
Novakova, Olga .
DRUG RESISTANCE UPDATES, 2006, 9 (03) :111-122
[4]   LIRIODENINE, A NITROGEN-CONTAINING PIGMENT OF YELLOW POPLAR HEARTWOOD (LIRIODENDRON-TULIPIFERA, L) [J].
BUCHANAN, MA ;
DICKEY, EE .
JOURNAL OF ORGANIC CHEMISTRY, 1960, 25 (08) :1389-1391
[5]   Structure-radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants [J].
Cai, Yi-Zhong ;
Sun, Mei ;
Xing, Jie ;
Luo, Qiong ;
Corke, Harold .
LIFE SCIENCES, 2006, 78 (25) :2872-2888
[6]   Bis-intercalative dinuclear platinum(II) 6-phenyl-2,2′-bipyridine complexes exhibit enhanced DNA affinity but similar cytotoxicity compared to the mononuclear unit [J].
Chan, HL ;
Ma, DL ;
Yang, MS ;
Che, CM .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2003, 8 (07) :761-769
[7]   Plant natural products with leishmanicidal activity [J].
Chan-Bacab, MJ ;
Peña-Rodríguez, LM .
NATURAL PRODUCT REPORTS, 2001, 18 (06) :674-688
[8]  
Chang Hui-Chiu, 2004, Kaohsiung Journal of Medical Sciences, V20, P365, DOI 10.1016/S1607-551X(09)70172-X
[9]   DNA binding studies of ruthenium(II) complexes containing asymmetric tridentate ligands [J].
Chao, H ;
Mei, WJ ;
Huang, QW ;
Ji, LN .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2002, 92 (3-4) :165-170
[10]   Non-platinum chemotherapeutic metallopharmaceuticals [J].
Clarke, MJ ;
Zhu, FC ;
Frasca, DR .
CHEMICAL REVIEWS, 1999, 99 (09) :2511-2533